Ar Asset Management Inc Prometheus Biosciences, Inc. Transaction History

Ar Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$103.46 - $126.29 $41,384 - $50,516	-400 Reduced 0.79%	50,414 $5.41 Million
Q4 2022 Feb 01, 2023	SELL	$36.06 - $117.21 $8,401 - $27,309	-233 Reduced 0.46%	50,814 $5.59 Million
Q3 2022 Oct 31, 2022	BUY	$28.17 - $59.01 $28,170 - $59,010	1,000 Added 2.0%	51,047 $3.01 Million
Q2 2022 Aug 03, 2022	BUY	$22.39 - $38.94 $496,834 - $864,078	22,190 Added 79.66%	50,047 $1.41 Million
Q4 2021 Feb 07, 2022	BUY	$22.28 - $39.54 $620,653 - $1.1 Million	27,857 New	27,857 $1.1 Million

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Ar Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Ar Asset Management Inc with notifications on news.